What is the diagnosis in a 42-year-old woman presenting with sudden flexion contracture of the distal tip of the right middle finger without trauma, consistent with a flexor tendon nodule catching at the A1 pulley?

Diagnosis: Trigger Finger (Stenosing Tenosynovitis)

The diagnosis is trigger finger (stenosing tenosynovitis), where a nodule on the flexor tendon becomes trapped at the A1 pulley level—not outside the tendon sheath as you described, but rather the nodule catches as it attempts to pass through the narrowed A1 pulley during finger flexion and extension.

Understanding the Pathophysiology

Your clinical description is essentially correct but requires anatomical clarification. In trigger finger, the flexor tendon develops a nodular thickening or the A1 pulley becomes stenotic. The nodule catches at the entrance to the A1 pulley (not outside the tendon sheath), creating the characteristic "triggering" or locking phenomenon. The sudden flexion contracture of the distal tip without trauma or overuse is classic for this condition, particularly in middle-aged women.

Your Treatment Approach

Your management was appropriate and follows accepted practice patterns:

• Digital block: Proper anesthetic technique
• Corticosteroid injection: You injected 2 mg dexamethasone diluted with 2 ml of 1% lidocaine directly into the nodule/A1 pulley region
• Splinting in extension: 48 hours of immobilization

Evidence for Your Treatment

While the provided guidelines focus primarily on overuse tendinopathies 1, the principles apply here. Locally injected corticosteroids may be more effective than oral NSAIDs in acute-phase pain relief 1. However, these guidelines note that corticosteroids "do not alter long-term outcomes" 1.

Critical Caveats and Pitfalls

1. Infection Risk

The most serious concern with trigger finger injection is postoperative infection, particularly in diabetic patients. Recent case series demonstrate that surgical site infections after trigger finger procedures can lead to devastating complications including flexor tenosynovitis, tendon rupture, and permanent functional deficit 2. While your patient received an injection (not surgery), sterile technique is paramount.

2. Alternative Diagnoses to Consider

You must rule out rare but important mimics:

• Giant cell tumor of the tendon sheath (TGCT): Can present identically to trigger finger with triggering symptoms 3, 4. These are benign but locally aggressive tumors requiring surgical excision
• Juvenile fibromatosis: Causes progressive flexion contracture (though typically in children) 5
• Forearm flexor muscle lesions: Can cause finger flexion deformity 6

If the patient fails conservative treatment or has atypical features (persistent swelling, palpable mass, progressive contracture), obtain MRI hand without IV contrast 7. MRI can identify tenosynovitis, tendinopathy, pulley injury, and soft-tissue masses 7. Ultrasound is also reasonable for evaluating tendon pathology and soft tissue abnormalities 7.

Expected Outcomes and Follow-Up

• Most patients (approximately 80%) with tendinopathies recover within 3-6 months with conservative treatment 1
• If triggering persists after your injection and splinting, the patient may require:
  • Repeat corticosteroid injection (though evidence shows no long-term benefit) 1
  • Surgical A1 pulley release if conservative measures fail after 3-6 months 1

What to Monitor

• Resolution of triggering within days to weeks
• Any signs of infection (increased pain, erythema, warmth, purulent drainage)
• Persistent or worsening flexion contracture suggesting alternative diagnosis
• Development of palpable mass suggesting TGCT

If symptoms persist beyond 2-3 weeks or worsen, obtain imaging (ultrasound or MRI) to exclude alternative diagnoses before proceeding with further injections or surgery 7, 3, 4.